Sanara MedTech Q4 Earnings Call Highlights
Sanara MedTech (NASDAQ:SMTI) reported fourth-quarter and full-year 2025 results highlighting record annual revenue, improved profitability, and progress in its transition to a "pure-play" surgical company following the wind-down of its Tissue Health Plus (THP) segment.
Full-year results top $100 mi...